Gamma Knife Surgery for Residual or Recurrent Craniopharyngioma After Surgical Resection: A Multi-institutional Retrospective Study in Japan.
craniopharyngioma
gamma knife
radiosurgery
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
12 Feb 2020
12 Feb 2020
Historique:
entrez:
24
3
2020
pubmed:
24
3
2020
medline:
24
3
2020
Statut:
epublish
Résumé
Objective The optimal treatment for a craniopharyngioma has been controversial. Complete resection is ideal, but it has been difficult to obtain total resection in many cases because of intimate proximity to critical structures such as the optic pathway, hypothalamus, and pituitary gland. A growing number of studies have demonstrated the utility of radiosurgery in controlling residual or recurrent craniopharyngioma. However, most of them are small series. The aim of this multi-institutional study was to clarify the efficacy and safety of Gamma Knife (Elekta, Stockholm, Sweden) surgery for patients with a craniopharyngioma. Methods This was a multi-institutional retrospective study by 16 medical centers of the Japan Leksell Gamma Knife Society. Data on patients with craniopharyngiomas treated with Gamma Knife Surgery (GKS) between 1991 and 2013 were obtained from individual institutional review board-approved databases at each center. A total of 242 patients with craniopharyngioma were included in this study. The mean age of the patients was 41 (range, 3 to 86) years. The median follow-up time was 61.4 months (range, 3 to 180 months). The mean radiosurgery target volume was 3.1 ml (range, 0.03-22.3 ml), and the mean marginal dose was 11.4 Gy (range, 8-20.4 Gy). Results Two-hundred twenty patients were alive at the time of the last follow-up visit. The three-, five-, and 10-year overall survival rates after GKS were 95.4%, 92.5%, and 82.0%, respectively. The three-, five-, and 10-year progression-free survival rates after GKS were 73.1%, 62.2%, and 42.6% respectively. The rate of radiation-induced complications was 6.2%. Conclusion GKS is effective for controlling the tumor growth of craniopharyngiomas with an acceptable complication rate.
Identifiants
pubmed: 32201653
doi: 10.7759/cureus.6973
pmc: PMC7075476
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e6973Informations de copyright
Copyright © 2020, Tsugawa et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
World Neurosurg. 2019 Jan 3;:
pubmed: 30610976
J Neurooncol. 2018 Oct;140(1):135-143
pubmed: 29987747
Radiat Oncol. 2014 Sep 16;9:203
pubmed: 25227427
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):189-95
pubmed: 8407391
J Clin Neurosci. 2012 Jul;19(7):1005-8
pubmed: 22595354
Stereotact Funct Neurosurg. 2009;87(6):360-7
pubmed: 19752595
J Neurosurg. 1986 Jul;65(1):22-7
pubmed: 3712025
Radiother Oncol. 2007 Jan;82(1):90-5
pubmed: 17161483
J Neurosurg. 1990 Jul;73(1):3-11
pubmed: 2352020
Pituitary. 2006;9(4):323-6
pubmed: 17080265
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):64-71
pubmed: 20005637
J Neurosurg. 1998 Oct;89(4):547-51
pubmed: 9761047
Neurosurgery. 2010 Apr;66(4):688-94; discussion 694-5
pubmed: 20190668
J Neurooncol. 2012 Feb;106(3):571-7
pubmed: 21861196
J Neurooncol. 2010 Jun;98(2):239-47
pubmed: 20422439
Radiother Oncol. 1993 Apr;27(1):13-21
pubmed: 8327728
J Clin Neurosci. 1999 Nov;6(6):527-30
pubmed: 18639199
Nagoya J Med Sci. 2012 Feb;74(1-2):141-7
pubmed: 22515120
J Neurosurg. 2014 Dec;121 Suppl:167-78
pubmed: 25434950
Med Pediatr Oncol. 2003 Apr;40(4):214-8
pubmed: 12555247
Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):255-63
pubmed: 10760417
J Neurosurg. 1999 Feb;90(2):251-7
pubmed: 9950495
Neurosurgery. 2010 Nov;67(5):1341-9; discussion 1349
pubmed: 20871436
J Neurosurg. 1999 Feb;90(2):237-50
pubmed: 9950494
J Neurosurg. 2007 Jan;106(1 Suppl):3-12
pubmed: 17233305
J Neurosurg. 2002 Dec;97(5 Suppl):613-22
pubmed: 12507107
Pituitary. 2009;12(4):352-9
pubmed: 19130248
J Neurosurg. 1985 May;62(5):648-56
pubmed: 3989587
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):492-9
pubmed: 12243827